Industry News
Melanoma Risk Lower In Women Who Take Aspirin
Mar 11, 2013
Women who take aspirin on a regular basis have a lower risk for developing melanoma, according to the largest US study ever conducted into potential ways to prevent this most dangerous form of skin cancer. The researchers, from Stanford University School of Medicine, also found that the longer the participants took aspirin, the lower their risk... Read More
Identifying Mechanism Behind Treatment Resistance In Melanoma Suggests Possible Strategy For Improvement
Mar 11, 2013
A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, which will be published in Cancer Cell and have been released online, suggest a strategy to improve the effectiveness of currently available targeted therapies... Read More
Sudden Exhaustion Syndrome: Differentiating Between Types Of Cancer-Related Fatigue
Mar 11, 2013
The fatigue experienced by patients undergoing cancer treatments has long been recognized by health care providers, although its causes and ways to manage it are still largely unknown. A Wayne State University researcher believes the condition affects some patients much more than others and is trying to determine the nature of that difference. Horng-Shiuann Wu, Ph.D... Read More
Trio Of Biomarkers May Help Identify Kidney Cancer In Early Stages
Mar 11, 2013
Biomarkers could help catch otherwise hard-to-detect cancer. Three-marker assay has high sensitivity and specificity. Researchers are seeking FDA approval... Read More
Molecular Switch Discovered That Turns On Self-Renewal Of Liver Damage
Mar 11, 2013
The liver is one of the few organs in our body that can regenerate itself, but how it occurs is a biological mystery. New research from BRIC, University of Copenhagen and the Finsen Laboratory, Rigshospitalet, has identified a protein complex that acts as a molecular switch turning on a self-regeneration program in the liver... Read More
First Evidence Of The Involvement Of A Histone Variant Protein As An Epigenetic Barrier To Induced Pluripotency
Mar 10, 2013
Researchers from the Icahn School of Medicine at Mount Sinai have discovered that a particular protein prevents normal cells from being reprogrammed into cells that resemble stem cells, providing new insight into how they may lose their plasticity during normal development. This finding has broad-reaching implications for how cells change during both normal and disease development... Read More
First-Of-Its-Kind Ultrafast Detection Of Microbe And Cancer Cell Mutations Could Lead To More Precise Investigations Of Therapeutic Treatments
Mar 10, 2013
Scientists at A*STAR's Genome Institute of Singapore (GIS) have developed a novel technique to precisely monitor and study the evolution of micro-organisms such as viruses and bacteria. This is an extremely important capability as it allows scientists to investigate if new drugs designed to kill them are working, and catch the development of resistance early on... Read More
Global Management Of Anemia In Children On Dialysis
Mar 10, 2013
Children on dialysis who have anemia and who require high doses of drugs to treat it have an increased risk of dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings provide new insights that may help improve the health of children with kidney failure... Read More
Hemophilia Mystery Solved
Mar 10, 2013
An Australian researcher has found the third and final missing piece in the genetic puzzle of an unusual form of hemophilia, more than 20 year after he discovered the first two pieces. Professor Merlin Crossley, of the University of New South Wales, and his international team studied the blood-clotting disorder, hemophilia B Leyden, which is unusual because symptoms improve after puberty... Read More
Bathing Abdomen In Chemotherapy Gives Ovarian Cancer Patients Better Chance Of Survival
Mar 09, 2013
More Women Should Receive Intraperitoneal Treatment, Suggests 10-Year Follow-up Patients with advanced ovarian cancer who undergo intensive treatment with chemotherapy that bathes the abdomen are significantly more likely to live longer than those who receive standard intravenous (IV) chemotherapy, according to a study that analyzed long-term follow-up from two landmark Gyne... Read More
Previous Page Next Page